Investor Group Recommends Stockholders Vote the WHITE Proxy Card for Boardroom Change at Pasithea Therapeutics
Camac Partners and affiliates, the largest external stockholder of Pasithea Therapeutics Corp. (NASDAQ: KTTA), are advocating for the removal of the Company’s Board of Directors.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Believes Removing All Incumbent Directors Will Position Pasithea to Enhance Corporate Governance, Improve Capital Allocation and Deliver Long Term Value
Urges Stockholders to Vote for ALL Proposals on the WHITE Proxy Card at Pasithea’s
“Our singular goal in this campaign has been to help put Pasithea back on the path to create value for stockholders. We are deeply disappointed that Pasithea has scheduled the Special Meeting to occur with just a few days of notice and over a holiday period. This is a stunning disregard for stockholder rights, and it is another in a long line of actions—including multiple dilutive acquisitions—taken by the incumbent Board that are calculated to disenfranchise stockholders. We strongly believe that it is time for stockholders to take back their Company and vote to remove all of Pasithea’s sitting directors.
We urge our fellow stockholders to vote to improve Pasithea at the Special Meeting by voting FOR all matters on the WHITE proxy card.”
***
VOTE THE WHITE PROXY CARD TODAY
If you have any questions on how to vote your shares on the WHITE proxy card, please contact
***
View source version on businesswire.com: https://www.businesswire.com/news/home/20221122005823/en/
For Investors:
ddelaney@concordinvestmentpartners.com
info@investor-com.com
For Media:
ckiaie@longacresquare.com / arabinovich@longacresquare.com
Source: